Biggest News Aggregation in the World
📰 Mark Dole News

Mark Dole News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Mark Dole. Real-time updates on events, politics, business and more.

Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK279 a Highly Selective Oral TYK2 Inhibitor for the Treatment of Active Psoriatic Arthritis

Takeda TSE4502NYSETAK today announced positive topline results from its randomized doubleblind placebocontrolled multipledose Phase 2b trial evaluating TAK279 an investigational oral allosteric tyrosine kinase 2 TYK2 inhibitor with next generation selectivity in people with active psoriatic arthritis.
New Orleans United States Mark Dole Jun Saito Greenwood Carriero Takeda Pharmaceuticals

Takeda Announces Positive Results in Phase 2b Study of Investigational TAK-279, an Oral, Once-Daily

Results for TAK-279 (Formerly NDI-034858) Show a Significantly Greater Proportion of Patients Achieved Psoriasis Area and Severity Index (PASI) 75 at Doses ≥5mg at 12 Weeks1At the Highest Dose of TAK-279, 46% of Patients Achieved PASI 90 and 33% Achieved PASI 100 at 12 Weeks, Indicating a Near-Total or Total Clearan...
United States New Orleans April Armstrong Mark Dole Christopher Oreilly American Academy Of Dermatology Association

Apellis to Showcase Leadership in Retina at Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Apellis to Showcase Leadership in Retina at Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting Nachrichtenquelle: globenewswire  |  16.04.2021, 18:44  |  82  10 accepted abstracts include five oral presentations from pioneering artificial intelligence (AI) collaboration Presentations support the potential of intravitreal pegcetacoplan, an investigational targeted C3 therapy, as the first treatment for ge...
United States Intravitreal Pegcetacoplan Ursula Schmidt Erfurth Mark Dole Drug Administration Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science